Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC16A3 |
Upstream (Parents) |
---|
(<<) ALAD → SLC16A3 |
(<<) MAOB → SLC16A3 |
(<<) ADAMTSL3 → SLC16A3 |
(<<) FCHO1 → SLC16A3 |
(<<) PPAP2B → SLC16A3 |
(<<) HPS5 → SLC16A3 |
Downstream (Children) |
---|
SLC16A3 → SEMA6D (>>) |
SLC16A3 → THEG (>>) |
SLC16A3 → PRR4///PRH2///PRH1///PRB4///PRB1 (>>) |
SLC16A3 → C1orf61 (>>) |
SLC16A3 → SSX2 (>>) |
SLC16A3 → CLSPN (>>) |
SLC16A3 → RGR (>>) |
SLC16A3 → IFNA7 (>>) |